Table 5.
multivariate analyses of factors predicting higher Gleason score on biopsies
| Variable | Odds ratio estimates | ||
|---|---|---|---|
| Point estimate | 95% Confidence interval | P-Value | |
| Post USPSTF recommendation | 2.006 | 1.477–2.725 | <.0001 |
| Post CTFPHC recommendation | 1.359 | 0.980–1.868 | 0.058 |
| Age at diagnosis | 1.047 | 1.032–1.063 | <.0001 |
| Baseline PSA | 1.074 | 1.032–1.063 | <.0001 |
| Baseline prostate volume | 0.990 | 0.983–0.997 | 0.006 |
| Baseline PSA density | 1.181 | 0.596–2.343 | 0.633 |
| Number of cores per biopsy | 1.035 | 0.953–1.124 | 0.409 |
| TRUS operator (Urologist versus Radiologist) | 1.326 | 0.989–1.778 | 0.060 |
| Pathology reviewer (F.B. versus others) | 1.013 | 0.793–1.294 | 0.916 |